Explore the full record of transactions filed by Jean-Luc SOUCHE, Director. Insider active across 1 companies, notably AMOEBA. Cumulatively, 9 filings have been published. Total volume traded: €17k. The latest transaction was disclosed on 6 March 2025 — Acquisition. Regulator: AMF. All data is free.
9 of 9 declarations
Jean-Luc Souche is a well-known figure in the French biocontrol and biosolutions ecosystem, closely associated with the listed company Amoéba. He served the company in operational business development roles, including as Biocontrol Business Developer, before being appointed as a director in 2023. Company documents indicate that he later continued in that board role until his resignation took effect at the end of the combined general meeting held on 26 June 2025. His career is rooted in the life sciences, with more than 30 years of experience in crop protection and agricultural innovation. Before joining Amoéba in 2018, he was the general manager of Agrauxine, a biological crop protection start-up, and later became responsible for business development after Agrauxine was acquired by the Lesaffre group. He also managed the construction of a biotech plant in Malaysia for Metabolic Explorer and held technical and marketing positions in France and abroad at Rhône-Poulenc Agrochimie, where he contributed to the launch of new maize herbicides and to the development of seed-treatment technologies. At Amoéba, Jean-Luc Souche played an important role in advancing the company’s commercial and industrial strategy. He was involved in market development, regulatory positioning and field validation work, particularly around biocontrol applications in vineyards and broad-acre crops. He appeared in multiple company communications linked to field trials, research partnerships and the company’s pre-commercial strategy. His profile combines technical expertise, crop-protection market knowledge and regulatory awareness, making him a useful executive profile during Amoéba’s transition from R&D toward industrial deployment.